Mediclinic International Plc

Mediclinic (MDC)

Company name:Mediclinic International Plc
Company Description:Mediclinic is a private hospital group with three operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing cost-effective acute care specialised hospital services.
EPIC:MDCTrading Currency:GBX
Market Sector:F25FISIN:GB00B8HX8Z88
Market Segment:STMMShare Type:DE
WWW Address: 10P
 Price Price Change [%] Bid Offer Open High Low Volume
 286.80 0.0 [0.00] 284.80 285.20 - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 2,114.42 737.24 0.08 -43.40 - - - 353.10 - 232.40

Mediclinic Key Figures

(at previous day's close)
Market Cap.2,114.42m
Shares In Issue737.24m
Prev. Close286.80
PE Ratio- 
Dividend Yield-%
EPS - basic-43.40p
Dividend PS-p
Dividend Cover- 
Cash Flow PS61.85p
Return On Equity (ROE)-11.07%
Operating Margin-8.92%
PEG Factor- 
EPS Growth Rate-111.71%
Dividends PS Growth Rate-%
Net Debt3,622.00m
Gross Gearing56.82%
Quick Assets1,127.00m
Net Working Capital462.00m
Intangibles / Fixed Assets20.46%
Turnover PS418.18p
Pre-Tax Profit PS-37.30p
Retained Profit PS-51.41p
Cash PS44.63p
Net Cash PS-59.68p
Net Tangible Asset Value PS *233.17p
Net Asset Value PS407.33p
Spread0.40 (0.14%) 

Mediclinic Balance Sheet


Share Price Performance

Sample Period HighLow
1 week294.60284.40
4 weeks306.60283.00
12 weeks306.60266.40
1 year353.10232.40

Share Price Chart (5 years)

Mediclinic Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week288.80-2.00-0.69284.400.45288.66
4 weeks296.00-9.20-3.11283.000.45293.16
12 weeks276.4010.403.76266.400.59288.58
26 weeks262.8024.009.13257.600.60288.76
1 year353.10-66.30-18.78232.400.83278.09
3 years578.00-291.20-50.38232.401.26385.21
5 years921.50-634.70-68.88232.401.34550.16

Mediclinic Key Management Ratios

Mediclinic Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio3.89 
PE Ratio- 
Tobin's Q Ratio 0.32 
Tobin's Q Ratio (excl. intangibles)0.40 
Dividend Yield-%
Market-to-Book Ratio0.73 
Price-to-Pre-Tax Profit PS-7.69 
Price-to-Retained Profit PS-5.58 
Price-to-Cash Flow PS4.64 
Price-to-Sales PS0.69 
Price-to-Net Tangible Asset Value PS1.15 
Price-to-Cash PS6.43 
Net Working Capital PS62.67 
Price Pct to Working Capital PS4.58%
Earnings Yield-%
Average PE31.12 
Years in average2 
PE to PE average-%

Mediclinic Financial Ratios

(Leverage Ratios)
Debt Ratio51.45%
Debt-to-Equity Ratio1.06 
Debt-to-Equity Ratio (excl. Intgbl)1.74 
Debt-to-Equity Market Value1.50 
Net Gearing52.09%
Net Gearing (excl. Intangibles)62.63%
Gross Gearing56.82%
Gross Gearing (excl. Intangibles)68.32%
Gearing Under 1 Year11.06%
Gearing Under 1 Year (excl. Intgbl)13.30%
(Liquidity Ratios)
Net Working Capital to Total Assets6.64%
Current Ratio1.60 
Quick Ratio (Acid Test)1.47 
Liquidity Ratio0.43 
Cash & Equiv/Current Assets26.73%
(Solvency Ratios)
Enterprise Value5,080.42m
CFO/Attributable Profit- 
Total Debt/Equity Market Value1.87 
Total Debt/Sales1.28 
Total Debt/Pre-Tax Profit-14.37 
Total Debt3,951.00m
Total Debt/Net Current Assets8.55%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-13.35%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs3 
Beta (60-Mnth)Beta (36-Mnth)

Mediclinic Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-4.45%
Return On Assets (ROA)-4.78%
Net Profit Margin-10.38%
Assets Turnover0.46 
Return On Equity (ROE)-11.07%
Return On Investment (ROI)-5.32%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-12.29%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.02 
Fixed Assets Turnover0.56 
Current Assets Turnover2.63 
Net Working Capital Turnover 
Inventory Turnover32.11 
(Other Operating Ratios)
Total Assets-to-Sales2.17 
Debt Collection Period91.52Days

Mediclinic Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
14 Nov 2019InterimGBX3.2031/03/201931/03/202005/12/201906/12/201917/12/20193.20
23 May 2019FinalGBX4.7031/03/201831/03/201913/06/201914/06/201929/07/20197.90
15 Nov 2018InterimGBX3.2030/03/201830/09/201806/12/201807/12/201818/12/2018-
24 May 2018FinalGBX4.7031/03/201731/03/201814/06/201815/06/201830/07/20187.90
16 Nov 2017InterimGBX3.2030/03/201730/09/201707/12/201708/12/201718/12/2017-
24 May 2017FinalGBX4.7031/03/201631/03/201722/06/201723/06/201731/07/20177.90
10 Nov 2016InterimGBX3.2030/03/201630/09/201624/11/201625/11/201612/12/2016-
25 May 2016FinalGBX5.2431/12/201431/12/201516/06/201617/06/201625/07/20169.34
25 Aug 2015InterimGBX4.1030/12/201430/06/201503/09/201504/09/201505/10/2015-
30 Mar 2015FinalGBX9.0031/12/201331/12/201416/04/201517/04/201515/05/201512.70
12 Aug 2014InterimGBX3.7030/12/201330/06/201410/09/201412/09/201410/10/2014-
03 Mar 2014FinalGBX9.0031/12/201231/12/201312/03/201414/03/201411/04/20149.00

Mediclinic Fundamentals

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
pre tax profit307.0011.17%-479.00-16.69%-137.00-4.67%-275.00-8.92%m
attributable profit229.008.33%-492.00-17.14%-151.00-5.15%-320.00-10.38%m
retained profit167.006.07%-550.00-19.16%-210.00-7.16%-379.00-12.29%m
eps - basic (p)31.00 -66.70 -20.50 -43.40 
eps - diluted (p)31.00 -66.70 -20.50 -43.40 
dividends per share- - - - 

Mediclinic Balance Sheet

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
fixed assets fixed assets3,703.0049.89%3,590.0056.60%3,524.0054.82%4,358.0062.67%m
intangibles intangibles2,156.0029.05%1,406.0022.17%1,587.0024.69%1,171.0016.84%m
fixed investments fixed investments489.006.59%365.005.75%204.003.17%194.002.79%m
current assets - other current assets - other9.000.12%1.000.02%4.000.06%8.000.12%m
stocks stocks90.001.21%90.001.42%88.001.37%104.001.50%m
debtors debtors614.008.27%630.009.93%756.0011.76%790.0011.36%m
cash & securities cash & securities361.004.86%261.004.11%265.004.12%329.004.73%m
creditors - short creditors - short590.007.95%525.008.28%586.009.12%769.0011.06%m
creditors - long creditors - long2,668.0035.95%2,445.0038.55%2,576.0040.07%3,182.0045.76%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves4,086.0055.05%3,286.0051.81%3,151.0049.02%2,890.0041.56%m
prefs, minorities prefs, minorities78.001.05%87.001.37%115.001.79%113.001.62%m
NAV Basic- - - - 
NAV Diluted- - - - 

Mediclinic Cash Flow Statement

31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
Operating CF394.00345.00344.00456.00m
Pre-Financing CF176.0026.0046.00730.00m
Retained CF7.00-82.0012.0067.00m

Mediclinic Brokers

Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MMF)Broker/DealerCANAHOARGB21001
Jefferies International LtdMarket Maker(MMF)Broker/DealerJEFFJEFFGB2X
Liberum Capital LimitedMarket Maker(MMF)Broker/DealerLIBCLCAPGB21
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210308 07:31:32